文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血管内灌注增强用于重症监护:部分主动脉阻断治疗严重缺血再灌注休克

Endovascular Perfusion Augmentation for Critical Care: Partial Aortic Occlusion for Treatment of Severe Ischemia-Reperfusion Shock.
PubMed 文献 · Shock · 2019-01-01
一句话结论猪严重缺血再灌注休克模型中,在标准化重症监护基础上加用血管内灌注增强(部分主动脉球囊充盈)可减少静脉液体需求并提高平均动脉压。

研究在猪模型中通过25%控制性失血和45分钟完全主动脉阻断制造严重缺血再灌注休克状态,动物随机接受标准化重症监护(SCC,静脉液体加去甲肾上腺素,由算法控制平台输送)或EPACC加SCC。主要结局为重症监护阶段总静脉液体量和平均MAP。EPACC组平均MAP更高(65 mmHg vs 60 mmHg,P<0.01),处于目标MAP的时间比例更大(95.3% vs 51.0%,P<0.01),所需静脉液体更少(21 mL/kg vs 96 mL/kg,P<0.01)。EPACC组终末肌酐更高(2.3 mg/dL vs 1.7 mg/dL,P<0.01),但组织学肾细胞损伤无差异(P=0.16)。作者认为这是针对难治性休克或资源有限环境患者的一种新疗法的首次描述。

要点

  • 在猪严重缺血再灌注休克模型中,EPACC加SCC组平均MAP为65 mmHg(95%CI 65-66),SCC组为60 mmHg(95%CI 57-63),P<0.01。
  • EPACC组处于目标MAP的时间比例为95.3%(95%CI 93.2-97.4),SCC组为51.0%(95%CI 29.5-72.6),P<0.01。
  • EPACC组所需静脉液体为21 mL/kg(95%CI 0-42),SCC组为96 mL/kg(95%CI 76-117),P<0.01。
  • EPACC组终末肌酐为2.3 mg/dL(95%CI 2.1-2.5),SCC组为1.7 mg/dL(95%CI 1.4-2.0),P<0.01,但组织学肾细胞损伤无差异(P=0.16)。
  • 两组最大乳酸和终末乳酸均无差异。

适用人群与场景

  • 猪模型:经历25%控制性失血和45分钟完全主动脉阻断以制造严重缺血再灌注休克状态。

处置流程与药物剂量

  • 标准化重症监护(SCC)由静脉液体和去甲肾上腺素组成,通过算法控制平台输送。
  • EPACC组在SCC基础上加用部分主动脉球囊充盈。

研究设计与关键结果

  • 研究类型:动物实验(猪模型),比较SCC与EPACC加SCC。
  • 主要结局:EPACC组平均MAP高于SCC组(65 mmHg,95%CI 65-66 vs 60 mmHg,95%CI 57-63,P<0.01);EPACC组所需静脉液体少于SCC组(21 mL/kg,95%CI 0-42 vs 96 mL/kg,95%CI 76-117,P<0.01)。
  • 次要结局:EPACC组处于目标MAP的时间比例高于SCC组(95.3%,95%CI 93.2-97.4 vs 51.0%,95%CI 29.5-72.6,P<0.01);两组最大乳酸和终末乳酸无差异;EPACC组终末肌酐高于SCC组(2.3 mg/dL,95%CI 2.1-2.5 vs 1.7 mg/dL,95%CI 1.4-2.0,P<0.01),但组织学肾细胞损伤无差异(P=0.16)。
  • 基线特征无差异。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这是针对难治性休克或资源有限环境患者的一种新疗法的首次描述。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The resuscitation of patients in shock is materially intensive and many patients are refractory to maximal therapy. We hypothesized that partial inflation of an intra-aortic balloon, termed Endovascular Perfusion Augmentation for Critical Care (EPACC), would minimize material requirements while improving physiologic metrics.

METHODS: Swine underwent a 25% controlled bleed and 45 min of complete aortic occlusion to create a severe ischemia-reperfusion shock state. Animals received either standardized critical care (SCC) composed of IV fluids and norepinephrine delivered through an algorithmically controlled platform or EPACC in addition to SCC. Physiologic parameters were collected, and blood was sampled for analysis. Primary outcomes were total IV fluids and average MAP during the critical care phase. Differences (P < 0.05) were measured with t test (continuous data) and Wilcoxon rank-sum test (ordinal data).

RESULTS: There were no differences in baseline characteristics. There were no differences in the maximum lactate; however, animals in the EPACC group had a higher average MAP (EPACC 65 mmHg, 95% confidence interval [CI], 65-66; SCC 60 mmHg, 95% CI, 57-63; P < 0.01) and remained within goal MAP for a greater period of time (EPACC 95.3%, 95% CI, 93.2-97.4; SCC 51.0%, 95% CI, 29.5-72.6; P < 0.01). EPACC animals required less IV fluids when compared with the SCC group (EPACC 21 mL/kg, 95% CI, 0-42; SCC 96 mL/kg, 95% CI, 76-117; P < 0.01). There were no differences in final lactate. Animals in the EPACC group had a higher final creatinine (EPACC 2.3 mg/dL, 95% CI, 2.1-2.5; SCC 1.7 mg/dL, 95% CI, 1.4-2.0; P < 0.01), but there were no differences in renal cellular damage on histology (P = 0.16).

CONCLUSION: Using a swine model of severe shock, the addition of EPACC to SCC significantly reduced fluid resuscitation requirements and improved blood pressure. This is the first description of a new therapy for patients in refractory shock or in resource-limited settings.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Johnson MA, Tibbits EM, Hoareau GL, et al. Endovascular Perfusion Augmentation for Critical Care: Partial Aortic Occlusion for Treatment of Severe Ischemia-Reperfusion Shock. Shock. 2019. PMID: 29877961. doi:10.1097/SHK.0000000000001199

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。